What is patient payments for clinical trials?
Author: Elizabeth Smith, Director of Product Management, Patient Engagement at Suvoda
Posts by Suvoda:
Clinical trial budgeting faces pressure to modernize
Author:KatieRothstein,Director,DataDelivery,Suvoda
Using current fair market value...
From buzzword to backbone: How AI is reshaping clinical trial operations
A conversation with Suvoda CEO Jagath Wanninayake
Author: Elena Filimonova, Chief Marketing Officer
Selecting the right site payments solution for today’s clinical trials: what to look for
Author: Dave Hine, Associate Vice President, Financial Services
Study startup has enough demands on your attention. RTSM build shouldn't be one of them
Author: E.K. Koh, Chief Product Officer
Snapshot:
A new regulatory milestone: what the joint FDA and EMA’s AI principles can mean for clinical trial technology
Author: Elizabeth Lavin, Chief Quality Officer, Suvoda
IRT vs. RTSM: what’s the difference? What sponsors need to know when choosing clinical trial technology
Author: Heather Nonnemacher, Director of Services Solutions, Suvoda
Technology fragmentation is one of the biggest hidden risks in clinical trials
By Kathy Kohler, Vice President, Customer Success at Suvoda
What patients are asking for in clinical trials, according to the CISCRP 2025 survey
Editor: Dave Hine, Senior Director, Solutions Consulting at Suvoda
